From the Departments of Psychiatry (J.D.W.), Physiology (M.D.), and Neuroscience (M.D.), and Department of Neurology, Memory and Aging Center (B.K.K., A.N., A.K., B.L.M., K.P.R.), University of California, San Francisco; Department of Psychiatry (J.D.W.), San Francisco Veterans Affairs Medical Center; and Departments of Molecular Biosciences and Nutrition (P.H.), School of Veterinary Medicine, University of California, Davis.
Neurology. 2014 Feb 11;82(6):512-20. doi: 10.1212/WNL.0000000000000106. Epub 2014 Jan 10.
To investigate whether patients with behavioral variant frontotemporal dementia (bvFTD) have dysregulation in satiety-related hormonal signaling using a laboratory-based case-control study.
Fifty-four participants (19 patients with bvFTD, 17 patients with Alzheimer disease dementia, and 18 healthy normal controls [NCs]) were recruited from a tertiary-care dementia clinic. During a standardized breakfast, blood was drawn before, during, and after the breakfast protocol to quantify levels of peripheral satiety-related hormones (ghrelin, cortisol, insulin, leptin, and peptide YY) and glucose. To further explore the role of patients' feeding abnormalities on hormone levels, patients were classified into overeating and nonovereating subgroups based on feeding behavior during separate laboratory-based standardized lunch feeding sessions.
Irrespective of their feeding behavior in the laboratory, patients with bvFTD, but not patients with Alzheimer disease dementia, have significantly lower levels of ghrelin and cortisol and higher levels of insulin compared with NCs. Furthermore, while laboratory feeding behavior did not predict alterations in levels of ghrelin, cortisol, and insulin, only patients with bvFTD who significantly overate in the laboratory demonstrated significantly higher levels of leptin compared with NCs, suggesting that leptin may be sensitive to particularly severe feeding abnormalities in bvFTD.
Despite a tendency to overeat, patients with bvFTD have a hormonal profile that should decrease food intake. Aberrant hormone levels may represent a compensatory response to the behavioral or neuroanatomical abnormalities of bvFTD.
使用基于实验室的病例对照研究,探讨行为变异额颞叶痴呆(bvFTD)患者是否存在与饱腹感相关的激素信号失调。
从一家三级护理痴呆诊所招募了 54 名参与者(19 名 bvFTD 患者、17 名阿尔茨海默病痴呆患者和 18 名健康正常对照组[NCs])。在标准化早餐期间,在早餐方案之前、期间和之后抽取血液,以量化外周饱腹感相关激素(ghrelin、皮质醇、胰岛素、瘦素和肽 YY)和葡萄糖水平。为了进一步探讨患者进食异常对激素水平的作用,根据在单独的基于实验室的标准化午餐进食期间的进食行为,将患者分为过度进食和非过度进食亚组。
无论在实验室中的进食行为如何,bvFTD 患者而非阿尔茨海默病痴呆患者的 ghrelin 和皮质醇水平明显较低,胰岛素水平明显较高。此外,虽然实验室进食行为不能预测 ghrelin、皮质醇和胰岛素水平的变化,但只有在实验室中明显过度进食的 bvFTD 患者的瘦素水平明显高于 NCs,表明瘦素可能对 bvFTD 中特别严重的进食异常敏感。
尽管有过度进食的趋势,但 bvFTD 患者的激素谱应该会降低食物摄入量。异常的激素水平可能代表 bvFTD 的行为或神经解剖异常的代偿反应。